40 studies were found.

1.		Recruiting	BB-10901 in Treating Patients With Recurrent or Refractory Lung Cancer, Metastatic Carcinoid Tumor, or Other Solid Tumors Conditions: adult solid tumor; gastrointestinal carcinoid tumor; Neuroendocrine Carcinoma; Non-small cell lung cancer; pulmonary carcinoid tumor; ...
2.		Recruiting	Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy Conditions: Merkel Cell Carcinoma; Islet Cell Carcinoma; Neuroendocrine Carcinoma; Pituitary Tumor
3.		Recruiting	Diagnostic and Genetic Study to Identify Pancreatic Lesions in Patients With Von Hippel-Lindau Syndrome Conditions: Neuroendocrine Carcinoma; Pancreatic Cancer; von Hippel-Lindau Syndrome
4.		Recruiting	Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer Conditions: Colon Cancer; Non-small cell lung cancer; Rectal Cancer; Small Cell Lung Cancer
5.		Recruiting	Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
6.		Recruiting	FR901228 in Treating Patients With Recurrent Small Cell Lung Cancer Condition: Recurrent Small Cell Lung Cancer
7.		Recruiting	Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer Condition: Recurrent Small Cell Lung Cancer
8.		Recruiting	Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy Conditions: extensive stage small cell lung cancer; limited stage small cell lung cancer; Recurrent Small Cell Lung Cancer
9.		Recruiting	Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease Conditions: Non-small cell lung cancer; Small Cell Lung Cancer
10.		Recruiting	Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
11.		Recruiting	Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients with Sensitive Small Cell Lung Cancer (SCLC) Condition: Small Cell Lung Cancer
12.		Recruiting	Oblimersen in Treating Patients With Metastatic or Recurrent Merkel Cell Carcinoma Conditions: recurrent Merkel cell carcinoma; stage II Merkel cell carcinoma; stage III Merkel cell carcinoma
13.		Recruiting	Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer
14.		Recruiting	Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy Conditions: limited stage small cell lung cancer; Non-small cell lung cancer; Pulmonary Complications; Radiation Fibrosis
15.		Recruiting	Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Condition: limited stage small cell lung cancer
16.		Recruiting	Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer Conditions: stage III Merkel cell carcinoma; recurrent Merkel cell carcinoma; stage II Merkel cell carcinoma
17.		Recruiting	Induction Tirapazamine Combined With Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Condition: limited stage small cell lung cancer
18.		Recruiting	ZD6474 in Treating Patients With Small Cell Lung Cancer Conditions: extensive stage small cell lung cancer; limited stage small cell lung cancer
19.		Recruiting	Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Condition: limited stage small cell lung cancer
20.		Recruiting	A Phase I, Open-Label, Dose Escalation Study of Weekly Dosing with BB-10901, followed by a Phase II Efficacy Expansion Condition: Small Cell Lung Cancer
21.		Recruiting	Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer Condition: limited stage small cell lung cancer
22.		Recruiting	Interferon alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer Condition: Recurrent Small Cell Lung Cancer
23.		Recruiting	Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers Conditions: Non-small cell lung cancer; Small Cell Lung Cancer
24.		Recruiting	Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer Conditions: extensive stage small cell lung cancer; limited stage small cell lung cancer
25.		Recruiting	Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer
26.		Recruiting	Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer Condition: limited stage small cell lung cancer
27.		Recruiting	Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer
28.		Recruiting	Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
29.		Recruiting	Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer
30.		Recruiting	Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer
31.		Recruiting	Combination Chemotherapy With or Without Oblimersen in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer
32.		Recruiting	Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion in Patients with Pulmonary and Pleural Malignancies Conditions: Small Cell Carcinoma; Mesothelioma; Non-Small-Cell Lung Carcinoma
33.		Recruiting	Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors Conditions: recurrent breast cancer; recurrent gastric cancer; recurrent non-small cell lung cancer; recurrent ovarian epithelial cancer; ...
34.		Recruiting	Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer
35.		Recruiting	Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer
36.		Recruiting	Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplantation Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer Conditions: limited stage small cell lung cancer; extensive stage small cell lung cancer
37.		Recruiting	Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer Conditions: Non-small cell lung cancer; Small Cell Lung Cancer
38.		Recruiting	Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Conditions: Drug Toxicity; radiation toxicity; limited stage small cell lung cancer
39.		Recruiting	Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission Condition: limited stage small cell lung cancer
40.		Recruiting	Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer